Skip to content
Portage BioTech, LLC.
Portage BioTech, LLC.Portage BioTech, LLC.
  • about us
    • overview
    • leadership
  • our portfolio
    • PORT-2 & PORT-3 – iNKT agonists
    • PORT-1 – Intratumoral Amphiphilic Formulations
    • PORT-4 – Nanolipogel Formulations
    • PORT-5 – STING Agonist with VLP Delivery
  • news
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • contact
  • about us
    • overview
    • leadership
  • our portfolio
    • PORT-2 & PORT-3 – iNKT agonists
    • PORT-1 – Intratumoral Amphiphilic Formulations
    • PORT-4 – Nanolipogel Formulations
    • PORT-5 – STING Agonist with VLP Delivery
  • news
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • contact

Category Archives: Press Release

Portage Biotech Announces Participation in September 2021 Investor Conferences

Press ReleaseBy Portage Biotech, IncSeptember 10, 2021
...

Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year

Press ReleaseBy Portage Biotech, IncAugust 30, 2021
...

Portage Biotech Issues Letter to Shareholders

Press ReleaseBy Portage Biotech, IncAugust 12, 2021
...

Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2 for the Treatment of Melanoma and Non-Small Cell Lung Cancer (NSCLC)

Press ReleaseBy Portage Biotech, IncAugust 5, 2021
...

Portage Biotech Announces Results for Fiscal Year Ended March 31, 2021

Financial and Regulatory Reports, Press ReleaseBy Portage Biotech, IncJuly 28, 2021
...

Portage Biotech Added to Russell 2000® Index

Press ReleaseBy Portage Biotech, IncJune 29, 2021
...

Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares

Press ReleaseBy Portage Biotech, IncJune 24, 2021
...

Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares

Press ReleaseBy Portage Biotech, IncJune 23, 2021
...

Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics’ IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting

Press ReleaseBy Portage Biotech, IncJune 2, 2021
...

Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange

Press ReleaseBy Portage Biotech, IncApril 16, 2021
...
12345…
67891011
12
Copyright © All rights reserved Portage Biotech, Inc

terms of use   privacy policy   disclaimer

Go to Top